Portfolio company
Imeros
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Imeros develops an automated multisensory apparatus using touch and ultrasound sensors to identify hard inclusions in excised tumour tissue for pathologists and surgeons.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PolaSight
PolaSight develops a polarimetric imaging device for real-time tissue assessment for pathologists to accelerate intraoperative workflows during cancer surgery.
Marginum
This company manufactures fluorescence-based tissue monitoring devices for surgeons to identify cancerous cells in surgical suction waste during oncological procedures.
Lightpoint
This company develops miniaturised imaging and sensing tools for intra-operative cancer detection to assist surgeons during robot-assisted procedures.
Refined Diagnostics
This company develops AI-powered laser imaging systems for real-time, stain-free tissue analysis and cancer diagnostics for surgeons, pathologists, and hospitals.
Soundsafe Care
This company develops a robotic high-intensity focused ultrasound system for the non-invasive treatment of tumours in human and veterinary oncology patients.
Microvessel cancer diagnostic
This company develops high-definition ultrasound imaging software to help clinicians non-invasively differentiate between malignant and benign tumours by visualising small blood vessels.
AtMoves
AtMoves produces joint loading devices and imaging software to diagnose orthopedic prosthetic loosening for surgeons and patients.
Dermus
Dermus develops handheld high-frequency ultrasound devices and AI-powered cloud software for dermatologists to diagnose and monitor skin conditions such as cancer and inflammation.
